|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001483,
umls-concept:C0018270,
umls-concept:C0021469,
umls-concept:C0085862,
umls-concept:C0086418,
umls-concept:C0249197,
umls-concept:C0288472,
umls-concept:C0334227,
umls-concept:C0376358,
umls-concept:C1280500,
umls-concept:C1299583,
umls-concept:C1420626,
umls-concept:C1549571,
umls-concept:C1608386
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-7-30
|
|
pubmed:abstractText |
To assess the potential of p21 as a gene therapy treatment for prostate cancer, by introducing p21 into both androgen-dependent (AD) and -independent (AI) human prostate cancer cell lines via a recombinant adenoviral vector, Ad5CMV-p21, carrying human p21 cDNA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1464-4096
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
314-8
|
|
pubmed:dateRevised |
2006-7-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12887490-Adenoviridae,
pubmed-meshheading:12887490-Androgens,
pubmed-meshheading:12887490-Cell Division,
pubmed-meshheading:12887490-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:12887490-Cyclins,
pubmed-meshheading:12887490-Flow Cytometry,
pubmed-meshheading:12887490-Gene Therapy,
pubmed-meshheading:12887490-Gene Transfer Techniques,
pubmed-meshheading:12887490-Humans,
pubmed-meshheading:12887490-Male,
pubmed-meshheading:12887490-Prostatic Neoplasms,
pubmed-meshheading:12887490-Tumor Cells, Cultured
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The growth inhibitory effect of p21 adenovirus on androgen-dependent and -independent human prostate cancer cells.
|
|
pubmed:affiliation |
International Centre for Medical Research and Department of Urology, Kobe University School of Medicine, Kobe, Japan. gotoh@med.kobe-u.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
